Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
05/12/2011 | US20110112098 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
05/12/2011 | US20110112096 Pyrimidine derivatives as kinase inhibitors |
05/12/2011 | US20110112084 Bicyclic androgen and progesterone receptor modulator compounds and methods |
05/12/2011 | US20110112081 Inhibitors of janus kinases |
05/12/2011 | US20110112080 Oxazoline derivatives |
05/12/2011 | US20110112075 Chlorothiophene-amides as inhibitors of coagulation factors xa and thrombin |
05/12/2011 | US20110112071 Novel heterocyclidene acetamide derivative |
05/12/2011 | US20110112070 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
05/12/2011 | US20110112067 Inhibitors of the Human Aldosterone Sythase CYP11B2 |
05/12/2011 | US20110112060 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
05/12/2011 | CA2780149A1 Ire-1.alpha. inhibitors |
05/12/2011 | CA2780128A1 Aryl and heteroaryl sulfones as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
05/12/2011 | CA2779948A1 Carboxy oxazole or thiazole compounds as dgat-1 inhibitors useful for the treatment of obesity |
05/12/2011 | CA2778907A1 Deuterated 5,6-dihydro-1h-pyridin-2-one compounds |
05/12/2011 | CA2778161A1 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
05/12/2011 | CA2778115A1 Imidazole derivatives as ido inhibitors |
05/11/2011 | EP2319890A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
05/11/2011 | EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
05/11/2011 | EP2318402A2 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands |
05/11/2011 | EP2318401A2 Azaindole inhibitors of iap |
05/11/2011 | EP2318400A1 1,2,4-oxadiazole substituted piperidine and piperazine derivatives as smo antagonists |
05/11/2011 | EP2318397A2 Substituted indole sulfonamide compounds, their preparation and use as medicaments |
05/11/2011 | EP2318391A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
05/11/2011 | EP2318387A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
05/11/2011 | EP2318374A2 Insecticidal benzenedicarboxamide derivative |
05/11/2011 | EP2318370A1 Fluorinated heteroaryls |
05/11/2011 | EP2318367A1 Piperidine and pyrrolidine compounds |
05/11/2011 | EP2042171B1 Therapeutic or prophylactic agent for allergic dermatitis |
05/11/2011 | EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
05/11/2011 | CN102056924A Fused ring compounds and use thereof |
05/11/2011 | CN102056921A Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
05/11/2011 | CN102056917A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
05/11/2011 | CN102056916A Novel heteroaromatic amides and thioamides as pesticides |
05/11/2011 | CN102056894A Homocysteine synthase inhibitor |
05/11/2011 | CN102050798A 2-(2'-hydroxylphenyl)-benzothiazole derivative luminescent materials |
05/11/2011 | CN102050794A Quinoxalin derivative and organic LED (Light-Emitting Diode) containing same |
05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
05/11/2011 | CN101602747B Preparation and application of 3, 7-disubstituted-N-hexyl phenothiazine derivative |
05/11/2011 | CN101497610B Dithiazole ethylene compound containing 2,1,3-diazosulfide unit |
05/11/2011 | CN101072561B Diaminoalkane aspartic protease inhibitors |
05/11/2011 | CN101007804B 1,3-benzodioxole-2,2-dicarboxylic acid derivatives and their preparation method and medicinal uses |
05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
05/10/2011 | US7939662 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same |
05/10/2011 | US7939657 N-substituted benzene sulfonamides |
05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
05/10/2011 | US7939533 Dual NK1/NK3 receptor antagonists |
05/10/2011 | CA2614746C Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
05/10/2011 | CA2531170C Aztreonam l-lysine and methods for the preparation thereof |
05/10/2011 | CA2436935C Serine protease inhibitors |
05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
05/05/2011 | WO2011053701A1 Phenoxy-substituted pyrimidines as opioid receptor modulators |
05/05/2011 | WO2011053511A1 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
05/05/2011 | WO2011053508A1 ALKYL SUBSTITUTED ARYLINDENOPYRIMIDINES AND THEIR USE AS HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONISTS |
05/05/2011 | WO2011052888A2 (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or pharmaceutically acceptable salts thereof, method for preparing same, and pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases |
05/05/2011 | WO2011052532A1 Metal polydentate ligand complex |
05/05/2011 | WO2011051961A1 Compounds for the treatment of dyslipidemia and related diseases |
05/05/2011 | WO2011051958A1 Fungicidal pyrazolones |
05/05/2011 | WO2011051858A1 Imidazole derivatives as casein kinase inhibitors |
05/05/2011 | WO2011051673A1 Aminothiazole derivatives useful as klk1 inhibitors |
05/05/2011 | WO2011051540A1 Androgen receptor modulating compounds |
05/05/2011 | WO2011051244A1 Heteroarylpiperidine and -piperazine derivatives |
05/05/2011 | WO2011006803A9 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
05/05/2011 | WO2011006794A9 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
05/05/2011 | WO2010151737A3 Heterocyclic compounds and their uses as inhibitors of pi3 k activity |
05/05/2011 | WO2010147430A3 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same |
05/05/2011 | WO2010139981A3 Processes for preparing crystalline forms of dasatinib |
05/05/2011 | WO2010139979A3 Processes for preparing crystalline forms of dasatinib |
05/05/2011 | WO2010069494A8 Use of 5-pyridin-4yl(1,3)thiazole for treating phytopathogenic fungi |
05/05/2011 | US20110105749 Triazole compounds that modulate hsp90 activity |
05/05/2011 | US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
05/05/2011 | US20110105566 Fungicide hydroximoyl-tetrazole derivatives |
05/05/2011 | US20110105565 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
05/05/2011 | US20110105530 Organic compounds |
05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
05/05/2011 | US20110105506 Diaminoalkane aspartic protease inhibitors |
05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
05/05/2011 | US20110105495 CYCLOPENTATHIOPHENE MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
05/05/2011 | US20110105494 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |
05/05/2011 | US20110105491 Thiazolidine compounds as orexin receptor antagonists |
05/05/2011 | US20110105486 Thiazole derivatives |
05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
05/05/2011 | US20110105483 Triazole compounds that modulate hsp90 activity |
05/05/2011 | US20110105479 Inhibitors of Bruton's Tyrosine Kinase |
05/05/2011 | US20110105477 Compositions and methods relating to hiv protease inhibition |
05/05/2011 | US20110105460 Triazole derivative or salt thereof |
05/05/2011 | US20110105456 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
05/05/2011 | US20110105455 Phenoxy-substituted pyrimidines as opioid receptor modulators |
05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
05/05/2011 | US20110105436 Heteroaryl compounds, compositions, and methods of use in cancer treatment |
05/05/2011 | US20110105429 Thiazole-4-Carboxylic Acid Esters and Thioesters as Plant Protection Agents |
05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
05/05/2011 | DE102009048848A1 New bichromophoric dye, useful e.g. as pigments and dyes for dyeing purposes, and for decorative and artistic purposes, preferably for distempers and related colors including watercolor paints, watercolors and colors for inkjet printers |
05/05/2011 | CA2779124A1 Heteroaryl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antagonists |